Alector: Pay

Alector paid its 2 named executives $3.3M in total in FY2024 (Dec).

Pay of each named executive

Sara Kenkare-Mitra, Ph.D.Former President and Head of Research and Development
FY2023 (Dec)
1 year

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 3 peers with pay on file was $2.5M. CEO pay of Alector for that year is not on file.

  1. 1Larimar Therapeutics
  2. 2Assembly Biosciences
  3. 3Lineage Cell Therapeutics
  4. 4AlectorNot disclosed
  5. 5Acumen Pharmaceuticals, Inc.Not disclosed
  6. 6Camp4 Therapeutics CorporationNot disclosed
  7. 7Cassava Sciences, Inc.Not disclosed
  8. 8CervoMed Inc.Not disclosed
  9. 9Continuum Therapeutics, Inc.Not disclosed
  10. 10Gain TherapeuticsNot disclosed
  11. 11Generation Bio Co.Not disclosed
  12. 12Kyverna TherapeuticsNot disclosed
  13. 13Lexeo TherapeuticsNot disclosed
  14. 14Ovid Therapeutics Inc.Not disclosed
  15. 15ProMIS Neurosciences, Inc.Not disclosed
  16. 16Serina Therapeutics, Inc.Not disclosed
  17. 17Tenaya TherapeuticsNot disclosed
  18. 18Ventyx Biosciences, Inc.Not disclosed
  19. 19Werewolf Therapeutics, Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.